Results 41 to 50 of about 517,223 (251)
The aim was to evaluate nasal polyposis as a risk factor for nonadherence to continuous positive airway pressure (CPAP) treatment in patients with obstructive sleep apnea (OSA). This was a population-based, longitudinal analysis of patients starting CPAP
C. Bengtsson +4 more
semanticscholar +1 more source
An Unusual Presentation of Nasal Polyp: A Case Report on Ethmoid Polyposis [PDF]
Ethmoid polyposis are the nasal polyps which are developed from ethmoidal sinuses located between the nose and eyes. Usually it is allergic in nature and can be multiple, grape like masses. The estimated ethmoid polyposis prevalence in India is 4%.
Nayanthara, Ramesh +4 more
core +1 more source
Dupilumab is a fully human monoclonal antibody targeting interleukin (IL) 4 and IL13 pathways. We performed a retrospective observational study to evaluate the efficacy of dupilumab for the treatment of adult patients referred to our department, from ...
M. Napolitano +7 more
semanticscholar +1 more source
Introduction Nasal polyposis is a disease characterized by a mechanical dysfunction of the nasal mucosa, closely related to the unique makeup of its extracellular matrix, which develops as the result of an anomalous tissue remodeling process ...
Rogério Pezato +4 more
doaj +1 more source
Objective: Previous studies suggested that microRNAs played an important role in the progression of inflammation and remodeling of chronic rhinosinusitis with nasal polyposis.
Xiang Qing +5 more
semanticscholar +1 more source
Nasal polyps are common, affecting up to four percent of the population. Their etiology remains unclear, but they are known to have associations with allergy, asthma, infection, cystic fibrosis, and aspirin sensitivity. They present with nasal obstruction, anosmia, rhinorrhoea, post nasal drip, and less commonly facial pain.
Jonathan Ray, Newton, Kim Wong, Ah-See
openaire +3 more sources
BACKGROUND ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and nasal polyposis symptoms.
Tim W. Harrison +221 more
semanticscholar +1 more source
ABO and RhD Blood Groups in Nasal Polyposis [PDF]
Objective:The aim of this study was to determine ABO and RhD blood group distribution in nasal polyposis (NP) patients and whether there is a specific ABO or RhD blood phenotype associated with susceptibility to or protection with respect to development ...
Boris Jelavic +5 more
core +1 more source
Nasal Polyposis in mucopolysaccharidosis type II
Mucopolysaccharidosis (MPS) type II is a rare multisystem disorder resulting from the accumulation of breakdown products of glycosaminoglycans in the body tissues.
Sreedharan, Suja +3 more
core +1 more source
Nasal polyposis and the role of alphintern
Introduction Nasal polyposis is a chronic inflammatory disease of the nasal mucosa. The pathogenesis of nasal polyps is still not entirely known. This makes definitive treatment very challenging.
Agila Al-Barasi
doaj +1 more source

